Earnings Alerts

Israel Chemicals (ICL) Earnings: 3Q Net Income Falls Short of Estimates Despite Revenue Growth

By November 12, 2025 No Comments
  • ICL Group reported a third-quarter net income of $115 million, a 1.8% increase compared to the previous year.
  • The net income fell short of analysts’ estimates, which were $122.5 million.
  • Revenue for the third quarter rose by 5.7% year-over-year, reaching $1.85 billion, but was below the estimated $1.92 billion.
  • Operating income increased by 7.5% year-over-year to $230 million.
  • Diluted earnings per share (EPS) remained steady at 9 cents, missing the estimate of 10 cents.
  • Adjusted diluted EPS was reported at 10 cents, down from 11 cents the previous year, matching the analysts’ estimate of 10 cents.
  • The company confirmed its full-year 2025 guidance for specialties-driven EBITDA, expecting it to range between $0.95 billion and $1.15 billion.
  • Market analysts issued no buy ratings, maintained six hold ratings, and no sell ratings for ICL Group.

A look at Israel Chemicals Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth3
Resilience3
Momentum3
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Israel Chemicals Limited, a company that develops and markets chemical and fertilizer products in Israel, Europe, and the Americas, has received positive Smartkarma Smart Scores. With a value score of 4 and a dividend score of 4, Israel Chemicals is deemed to be strong in terms of both value and dividend payouts. This indicates that the company is currently attractive from a financial standpoint and has the potential to provide good returns to its investors.

Looking at the other Smart Scores, Israel Chemicals received a growth score of 3, a resilience score of 3, and a momentum score of 3. While not as high as the value and dividend scores, these scores suggest that the company is stable, showing moderate growth potential, resilience in challenging times, and a steady momentum in the market. Overall, the Smart Scores paint a favorable long-term outlook for Israel Chemicals, making it a company worth considering for investment.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars